1-3 of 3
Drew J. Winston
Close
Sort by
Journal Articles

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

Drew J. Winston, Jo-Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, Estil Vance, George J. Alangaden, Roy F. Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Stephen A. Villano, Michael Boeckh
Journal: Blood
Blood (2008) 111 (11): 5403–5410.
https://doi.org/10.1182/blood-2007-11-121558
Published: 2008
Journal Articles

Pharmacokinetics of Ganciclovir Following Oral Valganciclovir Versus Intravenous Ganciclovir in Allogeneic Hematopoietic Stem-Cell Transplant Patients with Stable Graft-Versus-Host Disease of the Gastrointestinal Tract.

Drew J. Winston, M.D., Voravit Ratanatharathorn, M.D., Lindsey Baden, M.D., Christos Emmanouilides, M.D., Don Gabriel, M.D., Sherry Li, W. Robert Lange, M.D.
Journal: Blood
Blood (2004) 104 (11): 2223.
https://doi.org/10.1182/blood.V104.11.2223.2223
Published: 2004
Journal Articles

Elimination of Aspergillus infection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment

Drew J. Winston, Christos Emmanouilides, Kathy Bartoni, Gary J. Schiller, Ronald Paquette, Mary C. Territo
Journal: Blood
Blood (2004) 104 (5): 1581–1582.
https://doi.org/10.1182/blood-2004-03-1025
Published: 2004